Literature DB >> 10793196

Agents which block potassium-chloride cotransport prevent sound-triggered seizures in post-ischemic audiogenic seizure-prone rats.

K H Reid1, S Z Guo, V G Iyer.   

Abstract

The purpose of this study was to determine whether the loop diuretics furosemide, bumetanide and ethacrynic acid, which block the KCC1 potassium-chloride transporter in the kidney loop of Henle and the KCC2 potassium-chloride transporter in neuronal membranes, would prevent sound-triggered seizures in post-ischemic audiogenic seizure-prone rats. The rats were infused with the test agent via tail vein shortly before being tested for seizure susceptibility by exposure to loud noise (an alarm bell) for 60 s. Sound exposures were repeated at intervals to determine the time course of the seizure suppression effect. All three loop diuretics suppressed sound-triggered seizures in post-ischemic rats tested 2 days to 4 weeks after the ischemic exposure. Furosemide 200 mg/kg had no effect in 4/4 rats made acutely audiogenic seizure-prone by infusion of bicuculline into the inferior colliculus, indicating that the effect was not due to general anti-seizure activity. Mannitol 2 g/kg had no effect in 6/6 post-ischemic rats, indicating that the effect was not due to diuresis or fluid shifts. These results are consistent with the hypothesis that the exposure to global ischemia caused an upregulation of the potassium-chloride transporter KCC2 in neurons which persisted for at least 4 weeks.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10793196     DOI: 10.1016/s0006-8993(00)02121-1

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  10 in total

1.  Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats.

Authors:  X Huang; J McMahon; J Yang; D Shin; Y Huang
Journal:  Neuroscience       Date:  2012-05-18       Impact factor: 3.590

2.  Reduction of KCC2 expression and GABAA receptor-mediated excitation after in vivo axonal injury.

Authors:  Junichi Nabekura; Tsuyoshi Ueno; Akihiko Okabe; Akiko Furuta; Toru Iwaki; Chigusa Shimizu-Okabe; Atsuo Fukuda; Norio Akaike
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

3.  Clustering of neuronal K+-Cl- cotransporters in lipid rafts by tyrosine phosphorylation.

Authors:  Miho Watanabe; Hiroaki Wake; Andrew J Moorhouse; Junichi Nabekura
Journal:  J Biol Chem       Date:  2009-08-13       Impact factor: 5.157

4.  Cannabinoid Exposure via Lactation in Rats Disrupts Perinatal Programming of the Gamma-Aminobutyric Acid Trajectory and Select Early-Life Behaviors.

Authors:  Andrew F Scheyer; Milene Borsoi; Jim Wager-Miller; Anne-Laure Pelissier-Alicot; Michelle N Murphy; Ken Mackie; Olivier J J Manzoni
Journal:  Biol Psychiatry       Date:  2019-09-05       Impact factor: 13.382

5.  Limitations of Current GABA Agonists in Neonatal Seizures: Toward GABA Modulation Via the Targeting of Neuronal Cl(-) Transport.

Authors:  Arjun Khanna; Brian Patrick Walcott; Kristopher T Kahle
Journal:  Front Neurol       Date:  2013-06-25       Impact factor: 4.003

Review 6.  The extracellular space and epileptic activity in the adult brain: explaining the antiepileptic effects of furosemide and bumetanide.

Authors:  Daryl W Hochman
Journal:  Epilepsia       Date:  2012-06       Impact factor: 5.864

7.  Diuretics as Antiepileptic Drugs: Should We Go with the Flow?

Authors:  Kevin J. Staley
Journal:  Epilepsy Curr       Date:  2002-03       Impact factor: 7.872

8.  Diuretics as Antiepileptic Drugs.

Authors:  Andres M. Kanner
Journal:  Epilepsy Curr       Date:  2002-03       Impact factor: 7.872

Review 9.  The role of GABA in the regulation of GnRH neurons.

Authors:  Miho Watanabe; Atsuo Fukuda; Junichi Nabekura
Journal:  Front Neurosci       Date:  2014-11-28       Impact factor: 4.677

10.  Furosemide prevents membrane KCC2 downregulation during convulsant stimulation in the hippocampus.

Authors:  Lulan Chen; Jiangning Yu; Li Wan; Zheng Wu; Guoxiang Wang; Zihan Hu; Liang Ren; Jing Zhou; Binbin Qian; Xuan Zhao; Jinwei Zhang; Xu Liu; Yun Wang
Journal:  IBRO Neurosci Rep       Date:  2022-04-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.